Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > NKTR Nektar Therapeutics > Detailed Quotes

NKTR Nektar Therapeutics

Watchlist
2.880
+0.080+2.86%
Close 12/01 16:00 ET
2.8800.0000.00%
Post Mkt Price 12/01 16:02 ET
High
3.015
Open
2.800
Turnover
41.41M
Low
2.730
Pre Close
2.800
Volume
14.78M
Market Cap
541.31M
P/E(TTM)
Loss
52wk High
15.945
Shares
187.95M
P/E(Static)
Loss
52wk Low
2.730
Float Cap
510.07M
Bid/Ask %
5.26%
Historical High
111.360
Shs Float
177.11M
Volume Ratio
7.19
Historical Low
2.450
Dividend TTM
--
Div Yield TTM
--
P/B
1.31
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
8.35%
Amplitude
10.18%
Avg Price
2.801
Lot Size
1
Float Cap
510.07M
Bid/Ask %
5.26%
Historical High
111.360
Shs Float
177.11M
Volume Ratio
7.19
Historical Low
2.450
Dividend TTM
--
P/B
1.31
Dividend LFY
--
Turnover Ratio
8.35%
Amplitude
10.18%
Avg Price
2.801
Lot Size
1
Price Forecast

No Data

News

Comment

No Data

Company Overview More
Nektar Therapeutics is a research-based biopharmaceutical company which engages in discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology. The firm focuses on using new chemistry approaches to make medicines to treat cancer and autoimmune diseases. The company was founded in 1990 and is headquartered in San Francisco, CA.
CEO: Mr. Howard W. Robin
Market: NASDAQ
Listing Date: 05/06/1994
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist